NEWS
View news from our Featured Companies.
Raffael Lichdi, DVM Joins ImmuCell’s Sales & Marketing Team
PORTLAND, Maine, Sept. 14, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer
Positive Results in Two Animal Models of Glioblastoma Multiform (GBM) demonstrated that Single Local Treatment of OncoPLEX Significantly Inhibited Tumor Growth and Prolonged SurvivalCompany Expects a Pre-IND Meeting with the U.S. FDA by Year End and Potential...
Ingredion and S&W Enter US Stevia Pilot Production Supply Agreement
Exclusive Agreement Enables Opportunity to Scale US Stevia SupplyWESTCHESTER, Ill. and LONGMONT, Colo., Sept. 9, 2021 -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, and S&W...
Aytu BioPharma Announces Formation of New Scientific Advisory Board to Support Development of AR101 for Vascular Ehlers-Danlos Syndrome
Chaired by Dr. Hal Dietz and joined initially by Dr. Xavier Jeunemaitre, Dr. Shaine Morris, Dr. Bart Loeys, and Dr. Peter Byers with additional advisors to be addedENGLEWOOD, CO / September 9, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical...
INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada
Provides platform to leverage the existing INVOcell product registration in Canada and ongoing work with leading embryologist, Ric Ross, to establish INVO Centers and enhance distribution into existing fertility clinicsSARASOTA, Fla., Sept. 9, 2021 -- INVO Bioscience,...
INVO Bioscience Announces Official Opening of “Bloom Fertility, an INVO Center” in Atlanta
Bloom Fertility, An INVO Center becomes the second JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla. and ATLANTA, Sept. 7, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device...
Aytu BioPharma to Present at Upcoming September Investor Conferences
ENGLEWOOD, CO / September 7, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced today that Josh Disbrow, Chairman and Chief Executive Officer will...
Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual AFRH Virtual Conference
Dr. Carlsson will be speaking on the topic of INVOcell® as an efficient, patient-centric fertility solution for the growing demand in AfricaSARASOTA, Fla., Sept. 3, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing...
Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
CUPERTINO, Calif., Sept. 02, 2021 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Mogo Completes Acquisition of Canadian Investment Dealer Fortification Capital Inc. – to be Renamed MogoTrade
Acquisition accelerates upcoming launch of MogoTrade commission free stock trading platform All figures in Canadian $ VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, today...
Arianne Phosphate Names Raphael Gaudreault as Chief Operating Officer
DAN: TSX-V (Canada) JE9N: FSE (Germany) DRRSF: OTC (USA) SAGUENAY, QC, Aug. 31, 2021 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
U.S. Sorghum Acreage to Potentially Expand with Help from First-Year Use of New Cropping Solution
LONGMONT, Colo., Aug. 27, 2021 -- S&W Seed Company (Nasdaq: SANW), a global integrated agricultural seed technology company, announced successful first-year deployment of the Double Team™ Sorghum Cropping Solution program. Developed by S&W and ADAMA...
Arianne Phosphate Reports Corporate and Financial Results for Second Quarter 2021
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, Aug. 26, 2021 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
Zoomd Reports Record 2Q2021 Financial Results, Highlighted by 97% YOY Revenue Growth
VANCOUVER, BC, Aug. 24, 2021 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) (https://www.zoomd.com) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing tech (MarTech) user-acquisition and engagement platform,...
ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®
PORTLAND, Maine, Aug. 24, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
Zoomd to Report Second Quarter 2021 Financial Results on August 24, 2021, with Conference Call on August 25, 2021
Conference call to be conducted on August 25, 2021 at 11 a.m. ET.VANCOUVER, BC, Aug. 20, 2021 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing tech (MarTech)...
S&W Announces Preliminary Fiscal 2021 Financial Results
LONGMONT, Colo., Aug. 19, 2021 -- S&W Seed Company (Nasdaq: SANW) today announced certain unaudited preliminary financial results for the fiscal year ended June 30, 2021. Preliminary Core Revenue (which the Company defines as total revenue, excluding product...
PolyPid to Present at First World Association Against Infection in Orthopaedics and Trauma Congress
Virtual Presentation to be led by PolyPid Co-Founder and CSO on August 28, 2021PETACH TIKVA, Israel, Aug. 17, 2021 -- PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma focusing on developing targeted, locally administered and prolonged-release therapeutics to...
INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update
Company to Host Conference Call Today at 4:30pm ET (Details Below)SARASOTA, Fla., Aug. 16, 2021 -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...
Modular Medical Expands Executive Team with Appointment Of Lynn O’Connor Vos as New CEO
O'Connor Vos Brings Deep Experience in Market Development, Commercializing Products and Patient AdvocacySAN DIEGO, CA / August 16, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without...
Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2021 Financial Results and Recent Business Highlights
-Closed Underwritten Public Offering of Common Stock and Warrants Resulting in Gross Proceeds of $34.5 Million -Expected to Initiate Pivotal Phase 3 Clinical Trial in Schizophrenia in Q4'21 -$35.8 Million in Cash as of June 30, 2021 CUPERTINO, Calif., Aug. 16, 2021 --...
LiqTech International Announces Second Quarter 2021 Financial Results
BALLERUP, Denmark, Aug. 16, 2021 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today reported second quarter 2021 financial results for the period ended...
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021
Bottom Line: Q2 2021 Net Income of $141,000 versus Q2 2020 Net Loss of ($766,000)PORTLAND, Maine, Aug. 12, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets...
SenesTech Announces 2021 Second Quarter Financial and Operational Results
Revenue Growth of 125% from the Second Quarter in 2020 and 82% SequentiallyPHOENIX, Aug. 12, 2021 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the first and only EPA...
PolyPid Ltd. Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Recruitment Progressing as Planned with Over 300 Patients Enrolled into Phase 3 SHIELD I Trial of D-PLEX100 in Abdominal Surgery FDA Agreed that a Single Pivotal Phase 3 Study is Sufficient for Potential Approval of D-PLEX100 for the Prevention of Surgical Site...